Dr. Craig Cole Talks About The Huge Gaps in Black Clinical Trial Participation

Patient success relies on a collaborative effort, and Dr. Craig Cole from Karmanos Cancer Institute emphasizes the importance of including Black patients in clinical trials. He highlights that enthusiasm from the entire treatment team can help dismantle barriers. As the Director of Clinical Research, Cole notes that while Black individuals represent 20% of multiple myeloma cases, they only account for 6% of trial participants. Patients often perceive a lack of support from staff, impacting their willingness to engage in studies. Cultivating a clinic-wide excitement can foster patient comfort and participation.